Federal Register / Vol. 79, No. 225 / Friday, November 21, 2014 / Notices 69493 

or focus attention on areas where 

communication, training or change in 

operation might improve delivery of 

products or services. These collections 

will allow for ongoing, collaborative and 

actionable communications between 

ACF and its customer and stakeholders. 

It will also allow feedback to contribute 

directly to the improvement of program 

management. 

This request is an extension of the 

‘‘generic fast-track’’ process offered to 

all government agencies by OMB in 

2010. Fast-track means each request 

receives approval five days after 

submission, if no issues are brought to 

ACF’s attention by OMB within the five 

days. 

Respondents 

ANNUAL BURDEN ESTIMATES

Instrument Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden hours 

per response 

Total burden 

hours 

Survey .............................................................................................................. 5,000 1 0.5 2,500 

Estimated Total Annual Burden 

Hours: 

In compliance with the requirements 

of Section 506(c)(2)(A) of the Paperwork 

Reduction Act of 1995, the 

Administration for Children and 

Families is soliciting public comment 

on the specific aspects of the 

information collection described above. 

Copies of the proposed collection of 

information can be obtained and 

comments may be forwarded by writing 

to the Administration for Children and 

Families, Office of Planning, Research 

and Evaluation, 370 L’Enfant 

Promenade SW., Washington, DC 20447, 

Attn: ACF Reports Clearance Officer. 

Email address: infocollection@

acf.hhs.gov. All requests should be 

identified by the title of the information 

collection. 

The Department specifically requests 

comments on: (a) Whether the proposed 

collection of information is necessary 

for the proper performance of the 

functions of the agency, including 

whether the information shall have 

practical utility; (b) the accuracy of the 

agency’s estimate of the burden of the 

proposed collection of information; (c) 

the quality, utility, and clarity of the 

information to be collected; and (d) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques or 

other forms of information technology. 

Consideration will be given to 

comments and suggestions submitted 

within 60 days of this publication. 

Robert Sargis, 

Reports Clearance Officer. 

[FR Doc. 2014–27558 Filed 11–20–14; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2011–N–0510] 

Agency Information Collection 

Activities; Proposed Collection; 

Comment Request; Substances 

Prohibited From Use in Animal Food or 

Feed 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing an 

opportunity for public comment on the 

proposed collection of certain 

information by the Agency. Under the 

Paperwork Reduction Act of 1995 (the 

PRA), Federal Agencies are required to 

publish notice in the Federal Register 

concerning each proposed collection of 

information, including each proposed 

extension of an existing collection of 

information, and to allow 60 days for 

public comment in response to the 

notice. This notice solicits comments on 

the recordkeeping requirements for 

substances prohibited for use in animal 

food or feed. 

DATES: Submit electronic or written 

comments on the collection of 

information by January 20, 2015. 

ADDRESSES: Submit electronic 

comments on the collection of 

information to http://

www.regulations.gov. Submit written 

comments on the collection of 

information to the Division of Dockets 

Management (HFA–305), Food and Drug 

Administration, 5630 Fishers Lane, Rm. 

1061, Rockville, MD 20852. All 

comments should be identified with the 

docket number found in brackets in the 

heading of this document. 

FOR FURTHER INFORMATION CONTACT: FDA 

PRA Staff, Office of Operations, Food 

and Drug Administration, 8455 

Colesville Rd., COLE–14526, Silver 

Spring, MD 20993–0002, PRAStaff@

fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: Under the 

PRA (44 U.S.C. 3501–3520), Federal 

Agencies must obtain approval from the 

Office of Management and Budget 

(OMB) for each collection of 

information they conduct or sponsor. 

‘‘Collection of information’’ is defined 

in 44 U.S.C. 3502(3) and 5 CFR 

1320.3(c) and includes Agency requests 

or requirements that members of the 

public submit reports, keep records, or 

provide information to a third party. 

Section 3506(c)(2)(A) of the PRA (44 

U.S.C. 3506(c)(2)(A)) requires Federal 

Agencies to provide a 60-day notice in 

the Federal Register concerning each 

proposed collection of information, 

including each proposed extension of an 

existing collection of information, 

before submitting the collection to OMB 

for approval. To comply with this 

requirement, FDA is publishing notice 

of the proposed collection of 

information set forth in this document. 

With respect to the following 

collection of information, FDA invites 

comments on these topics: (1) Whether 

the proposed collection of information 

is necessary for the proper performance 

of FDA’s functions, including whether 

the information will have practical 

utility; (2) the accuracy of FDA’s 

estimate of the burden of the proposed 

collection of information, including the 

validity of the methodology and 

assumptions used; (3) ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) 

ways to minimize the burden of the 

collection of information on 

respondents, including through the use 

of automated collection techniques, 

when appropriate, and other forms of 

information technology. 

mstockstill on DSK4VPTVN1PROD with NOTICES

69494 Federal Register / Vol. 79, No. 225 / Friday, November 21, 2014 / Notices 

Substances Prohibited From Use in 

Animal Food or Feed—21 CFR Part 589 

(OMB Control Number 0910–0627— 

Revision) 

This regulation prohibits the use of 

certain cattle origin materials in the 

food or feed of all animals to help 

prevent the spread of bovine spongiform 

encephalopathy (BSE) in United States’ 

cattle. BSE is a progressive and fatal 

neurological disorder of cattle that 

results from an unconventional 

transmissible agent. BSE belongs to the 

family of diseases known as 

transmissible spongiform 

encephalopathies (TSEs). All TSEs 

affect the central nervous system of 

infected animals. These measures will 

further strengthen existing safeguards 

against BSE. 

Description of Recordkeeping for 

Respondents: Rendering facilities, 

medicated feed manufacturers, livestock 

feeders. 

FDA estimates the burden of this 

collection of information as follows: 

TABLE 1—ESTIMATED ANNUAL RECORDKEEPING BURDEN 1

21 CFR Section 589.2001; substances 

prohibited from use in animal food or 

feed 

Number of 

recordkeepers 

Number of 

records per 

recordkeeper 

Total annual 

records 

Average 

burden per 

recordkeeper 

Total hours 

Operating and 

maintenance 

costs 

589.2001(c)(2)(vi) and (c)(3)(i) ................ 175 1 175 20 3,500 $59,500 

589.2001(c)(2)(ii) ...................................... 50 1 50 20 1,000 17,000 

589.2001(c)(3)(i)(A) .................................. 175 1 175 26 4,550 80,580 

Total .................................................. ........................ ........................ ........................ ........................ 9,050 157,080 

1There are no capital costs associated with this collection of information. 

The number of recordkeepers times 

the number of records per recordkeeper 

equals total annual records. Total 

annual records times average burden per 

recordkeeper equals total hours. 

Description of Respondents for 

Reporting: The final regulation on BSE 

(73 FR 22720) included a provision that 

exempts cattle materials prohibited in 

animal feed (CMPAF) from designated 

countries from the prohibition on its use 

in animal feed. A foreign country 

seeking this designation will submit a 

written request to FDA that includes a 

variety of information about the 

country’s BSE status (§ 589.2001(f)). 

During the past 6 years, FDA received 

2 requests from countries to be 

exempted from CMPAF restrictions. 

FDA estimates the reporting burden 

for this information collection as 

follows: 

TABLE 2—ESTIMATED ANNUAL REPORTING BURDEN 1

21 CFR Section 589.2001(f) Number of 

respondents 

Number of 

responses per 

respondent 

Total annual 

responses 

Average 

burden per 

respondent 

Total hours 

One-time (initial) burden ...................................................... 1 1 1 80 80 

Burden from future review ................................................... 1 1 1 26 26 

1There are no capital costs or operating costs associated with the collection of information. 

One-Time (initial) Reporting Burden 

There will be a one-time burden to 

countries that apply to FDA seeking to 

be designated as not subject to 

restrictions applicable to CMPAF. We 

estimate that each country that applies 

for an exclusion will spend 80 hours 

putting information together to submit 

to FDA. Table 2 row 1 presents the onetime burden for the exclusion. (See final 

BSE regulation at 73 FR 22754). 

Recurring Burden 

Countries that successfully petition 

FDA to be designated as exempt from 

certain BSE-related restrictions 

applicable to animal feed will be subject 

to future review by FDA to ensure that 

their designation remains appropriate. 

As part of this process, FDA may ask 

designated countries from time to time 

to confirm that their BSE situation and 

the information submitted by them in 

support of their original application 

remains unchanged. We assume it will 

take FDA and the designated country 

undergoing a review in the future about 

one third the time and effort it did when 

the information was submitted. Table 2 

row 2 presents the expected recurring 

burden. 

Dated: November 17, 2014. 

Leslie Kux, 

Associate Commissioner for Policy. 

[FR Doc. 2014–27518 Filed 11–20–14; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2011–N–0535] 

Agency Information Collection 

Activities; Proposed Collection; 

Comment Request; Notification of a 

Health Claim or Nutrient Content Claim 

Based on an Authoritative Statement 

of a Scientific Body 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA or we) is 

announcing an opportunity for public 

comment on our proposed collection of 

certain information by the Agency. 

Under the Paperwork Reduction Act of 

1995 (the PRA), Federal Agencies are 

required to publish notice in the 

Federal Register concerning each 

proposed collection of information, 

mstockstill on DSK4VPTVN1PROD with NOTICES